Published On : 2021-06-19

A NOVEL APPROACH towards managing NAFLD/ NASH patients, QRAHEP modulates and utilizes fat deposited/accumulated on the liver by various approaches like fatty acid transport leading to β-oxidation, promoting β-oxidation of fat inhibiting the synthesis of lipid (fat). It also regulates many co-factors involved in condition like inducing satiety- leading to fed state scenario- so there is no excessive dietary fat, attenuating the liver inflammatory cytokines- making the condition less severe and inhibition of cholesterol synthesis which is the main complication in these conditions.

© Frimline 2024. All rights reserved.